NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations
A. Drilon, J. Horan, A. Tangpeerachaikul, B. Besse, S. Ou, S. Gadgeel, D. Camidge, A. van der Wekken, Linh Nguyen-Phuong, Adam Acker, Clare Keddy, K. Nicholson, S. Yoda, S. Mente, Yuting Sun, J. Soglia, N. Kohl, J. Porter, M. Shair, V. Zhu, M. Davare, A. Hata, H. Pelish, Jessica J. Lin
Cancer Discovery